Global Medical REIT Inc (GMRE) Director Ronald Marston Purchases 2,830 Shares

Share on StockTwits

Global Medical REIT Inc (NYSE:GMRE) Director Ronald Marston acquired 2,830 shares of Global Medical REIT stock in a transaction on Monday, June 4th. The stock was acquired at an average cost of $8.86 per share, for a total transaction of $25,073.80. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.

Shares of GMRE traded up $0.14 during trading hours on Wednesday, hitting $9.44. 37,238 shares of the stock traded hands, compared to its average volume of 61,778. The company has a quick ratio of 0.14, a current ratio of 0.14 and a debt-to-equity ratio of 1.63. Global Medical REIT Inc has a 1-year low of $6.34 and a 1-year high of $10.05. The firm has a market capitalization of $196.84 million, a PE ratio of 17.48, a price-to-earnings-growth ratio of 1.23 and a beta of 0.51.

Global Medical REIT (NYSE:GMRE) last issued its quarterly earnings results on Monday, November 5th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.22). Global Medical REIT had a net margin of 8.00% and a return on equity of 1.91%. The firm had revenue of $14.00 million for the quarter, compared to analyst estimates of $14.34 million. Analysts anticipate that Global Medical REIT Inc will post 0.82 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 10th. Stockholders of record on Thursday, September 20th were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 8.47%. The ex-dividend date of this dividend was Wednesday, September 19th. Global Medical REIT’s dividend payout ratio (DPR) is presently 148.15%.

Several institutional investors and hedge funds have recently modified their holdings of GMRE. Citadel Advisors LLC acquired a new position in shares of Global Medical REIT during the second quarter valued at $194,000. A.R.T. Advisors LLC lifted its stake in shares of Global Medical REIT by 126.4% during the first quarter. A.R.T. Advisors LLC now owns 28,130 shares of the company’s stock valued at $195,000 after acquiring an additional 15,703 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in shares of Global Medical REIT during the first quarter valued at $224,000. Schwab Charles Investment Management Inc. lifted its stake in shares of Global Medical REIT by 32.4% during the second quarter. Schwab Charles Investment Management Inc. now owns 37,600 shares of the company’s stock valued at $334,000 after acquiring an additional 9,200 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Global Medical REIT by 77.6% during the first quarter. Dimensional Fund Advisors LP now owns 57,936 shares of the company’s stock valued at $403,000 after acquiring an additional 25,321 shares during the period. 42.01% of the stock is currently owned by institutional investors and hedge funds.

A number of equities analysts have commented on GMRE shares. Boenning Scattergood raised Global Medical REIT to a “buy” rating and set a $11.00 price objective on the stock in a research note on Wednesday. Zacks Investment Research raised Global Medical REIT from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a research note on Wednesday, July 18th. B. Riley set a $11.00 price objective on Global Medical REIT and gave the stock a “buy” rating in a research note on Friday, August 10th. Finally, Robert W. Baird started coverage on Global Medical REIT in a research note on Thursday, October 11th. They issued an “outperform” rating and a $11.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Global Medical REIT presently has a consensus rating of “Buy” and an average target price of $10.50.

TRADEMARK VIOLATION WARNING: This report was published by Week Herald and is the property of of Week Herald. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://weekherald.com/2018/11/07/global-medical-reit-inc-gmre-director-ronald-marston-purchases-2830-shares.html.

About Global Medical REIT

Global Medical REIT, Inc operates as a development stage company that intends to develop and manage a portfolio of healthcare real estate assets and properties. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Recommended Story: How mutual funds make money

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply